HBSAg 蛋白
HBsAg 宿主: Hepatitis B Virus (HBV) 宿主: Mammalian Cells Recombinant The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
HBsAg 宿主: Hepatitis B Virus (HBV) 宿主: Hepatitis B Virus (HBV) Native > 95 % pure
HBsAg 宿主: Hepatitis B Virus (HBV) 宿主: 酵母菌 Recombinant > 95 % pure ELISA
HBSAg 蛋白 by Origin
Find HBSAg 蛋白 for a variety of species such as anti-Hepatitis B Virus (HBV) HBSAg, anti-Human HBSAg. The species listed below are among those available. Click on a link to go to the corresponding products.
HBSAg 蛋白 by Source
Here you will find HBSAg 蛋白 proteins organized by several key sources. By clicking on a link, you can access the products. For additional sources, please use our search function.
HBSAg 蛋白 by 蛋白类型
Here you can find HBSAg 蛋白 proteins categorized by available protein types. Additional protein types can be located using our search function.
HBSAg 蛋白 by 应用范围
Find HBSAg 蛋白 validated for a specific application such as ELISA, EIA, WB. Some of the available applications are listed below. Click on a link to go to the corresponding products.
HBSAg 蛋白 by 生物活性
Find HBSAg 蛋白 with a specific 生物活性. The 生物活性 listed below are among those available. Click on a link to go to the corresponding products.
Popular HBSAg 蛋白
- (2)
- (1)
- (2)
Latest Publications for our HBSAg 蛋白
: "Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice." in: Biochemical and biophysical research communications, Vol. 504, Issue 4, pp. 865-870, (2019) (PubMed).: "Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes." in: Avicenna journal of medical biotechnology, Vol. 6, Issue 4, pp. 238-45, (2014) (PubMed).
: "Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array." in: Journal of immunological methods, Vol. 371, Issue 1-2, pp. 159-64, (2011) (PubMed).
: "Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination." in: Vaccine, Vol. 28, Issue 21, pp. 3672-8, (2010) (PubMed).
: "Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine." in: Antiviral research, Vol. 42, Issue 2, pp. 97-108, (1999) (PubMed).
